News

Matt Burton was issued with a one-match ban ... charge at the NRL Judiciary and will miss three matches. Latrell Mitchell copped a one-match ban for a high shot during his side's loss to ...
Globus Medical GMED has been analyzed by 5 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. Summarizing their recent assessments, the table ...
Wall Street expects a year-over-year increase in earnings on higher revenues when Globus Medical (GMED) reports results for the quarter ended March 2025. While this widely-known consensus outlook ...
Matthew Mitchell is a senior fellow in the Center for Human Freedom at the Fraser Institute and a senior affiliated scholar with the Mercatus Center at George Mason University. April 27 ...
AUDUBON, Pa., April 17, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal technology company, will announce its financial results for the first quarter ended March ...
AUDUBON, Pa., April 03, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced the completion of its previously disclosed ...
In a report released today, Ryan Zimmerman from BTIG maintained a Buy rating on Globus Medical (GMED – Research Report), with a price target of $88.00. The company’s shares closed last Friday ...
Clearly, options traders are pricing in a big move for Globus Medical shares, but what is the fundamental picture for the company? Currently, Globus Medical is a Zacks Rank #3 (Hold) in the ...
Matt Mitchell is a pianist and composer interested in the intersections of various strains of acoustic, electric, composed, and improvised new music. He currently composes for and leads several ...